Those who transition off these medications, while sustaining achieved weight loss nutritionally, report a better quality of life, with one Virta member sharing, Thank you so much for all of your help transitioning off this medication
Monitor weight, labs, and symptoms regularly
These medications have also shown potential in slowing CKD progression and reducing hypoglycemia risks (6)
Clinical trials of semaglutide, including the SUSTAIN and STEP programs, have not demonstrated increased incidence of thyroid cancer compared to placebo or active comparators
Phase 2 T2D trial, NEJM 2023) indicate that gastrointestinal adverse effects are the most frequently reported side effects, particularly during dose escalation